We imagine a future where permanent disability from brain injury no longer exists.
Modern neuroscience has discovered how the human brain can be intentionally rewired post-injury – but the tools do not exist yet.
1 in 3 people
will survive a stroke or traumatic brain injury in their lifetime – but still be left with
life-altering disability.
Our Solution
Get In and Get Out.
We believe the purpose of the ultimate brain-machine interface is
to heal the human brain.
Panaxium’s precision therapy BMI platform is built for surgeons
and neurologists to directly intervene, treat the injury, and leave
the patient to return to a life of normalcy.
An up close approach
Iontronic interface safely & selectively “speaks” the language of cells to direct precision healing.
It’s not just about the hardware: Precision healing requires advanced understanding of an injury
Panaxium’s proprietary MRI protocol & AI-assisted analysis
generates complete patient-specific representations of entire
functional networks.
This identifies specific disruption from damage, predicts natural
recovery, and aids planning for the implantation.
Together these technologies will enable the ultimate therapy: turning everyday activities into assisted recovery exercises.
In the OR, faster
Partnership with Synaptive Medical
Unlocking the ultimate brain-machine interface neuro-recovery therapy is not just about the device itself. It requires the ability to assess, plan, and strategize a personalized functional remapping to every patient’s specific injury.
Equity investment from leading brain-focused foundation will fund preclinical work required to begin human clinical trials. Toronto, Canada, April 10, 2023 – Bioelectronic medicine company Panaxium today announced that it has received an […]
Dr. Gilles Huberfeld, MD, PhD, is leading the 1st humans patient investigations of Panaxium's next-generation iontronic brain computer interface in 2023 in Paris, France.
Interactive symposium with leading experts and rising stars in the field will focus on defining the frontiers of bioelectronics and mapping future directions.
World-leader in cortical motor control research and Université de Montréal Professor is an expert in premotor cortex function and cortical plasticity following brain injury.
New hires will join world-renowned researchers leading groundbreaking development of bioelectronics materials and novel electronic devices to treat chronic disease.
NSF CAREER Award-winning Northwestern University biomedical engineer is developing new polymer-based bioelectronic materials that could enable next-generation diagnostic and therapeutic tools.
Groundbreaking brain researcher and Columbia University Assistant Professor is developing novel electronic devices that allow efficient interaction with biological substrates.